Alignment Healthcare, Inc. $ALHC Shares Sold by Charles Schwab Investment Management Inc.

Key Points

• Charles Schwab Investment Management Inc. reduced its holdings in Alignment Healthcare, Inc. by 2.9%, now owning 823,158 shares worth approximately $15.3 million.
• Analysts have issued mixed ratings on Alignment Healthcare, with one strong buy, five buys, and five holds, and a price target averaging $18.56.
• CEO John E. Kao sold 180,000 shares of the company's stock, decreasing his ownership by 10.39%, while corporate insiders collectively own 7% of the company's shares.

Charles Schwab Investment Management Inc. decreased its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 2.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 823,158 shares of the company's stock after selling 24,816 shares during the period. Charles Schwab Investment Management Inc. owned about 0.42% of Alignment Healthcare worth $15,327,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in ALHC. MCF Advisors LLC grew its holdings in shares of Alignment Healthcare by 87.6% in the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after purchasing an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new position in Alignment Healthcare in the 1st quarter worth about $42,000. Amalgamated Bank increased its position in shares of Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after acquiring an additional 616 shares during the period. Tower Research Capital LLC TRC raised its stake in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after acquiring an additional 6,286 shares in the last quarter. Finally, Dark Forest Capital Management LP purchased a new stake in shares of Alignment Healthcare in the fourth quarter valued at approximately $150,000. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Price Performance

ALHC traded down $0.26 on Monday, reaching $15.58. The company had a trading volume of 3,051,961 shares, compared to its average volume of 3,989,637. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66. Alignment Healthcare, Inc. has a 1 year low of $8.65 and a 1 year high of $21.06. The stock has a 50-day moving average price of $13.77 and a 200-day moving average price of $15.30.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $960.25 million. During the same quarter in the previous year, the firm earned ($0.13) earnings per share. The business's revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $16.00, for a total value of $400,000.00. Following the sale, the director directly owned 1,152,049 shares in the company, valued at $18,432,784. The trade was a 2.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Andreas P. Wagner sold 12,032 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $16.47, for a total value of $198,167.04. Following the completion of the transaction, the insider owned 192,043 shares of the company's stock, valued at $3,162,948.21. The trade was a 5.90% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 636,185 shares of company stock worth $9,235,468 in the last three months. Company insiders own 6.60% of the company's stock.

Analyst Upgrades and Downgrades

ALHC has been the subject of several recent research reports. UBS Group boosted their price target on shares of Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their target price for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price objective on the stock in a report on Monday. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. Finally, Zacks Research upgraded Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.